Cloudbreak Pharma Inc. has announced that its board of directors will convene on 31 August 2026 to review and approve the Group’s unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on a possible interim dividend.

The meeting will be chaired by Dr. Ni Jinsong, who serves as Chairman, Executive Director and Chief Executive Officer. The current Board comprises nine members: three executive directors (Dr. Ni Jinsong, Mr. Dinh Son Van, Dr. Yang Rong), three non-executive directors (Dr. Li Jun Zhi, Mr. Cao Xu, Mr. Xia Zhidong) and three independent non-executive directors (Ms. Nie Sijiang, Mr. Ma Yiu Ho Peter, Mr. Lee Alex Jao Jang).

No financial figures were disclosed in the announcement; full details are expected upon publication of the interim results following the scheduled meeting.